ACCESS Newswire
03 Jun 2023, 02:13 GMT+10
BOSTON, MA / ACCESSWIRE / June 2, 2023 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory and cancer diseases, today announced that Stephen Yoder, president and chief executive officer of Pieris, will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 9, 2023 at 10:00 a.m. ET in New York City.
To access the live webcast of Pieris's fireside chat, please use this link. A replay of the webcast will be available on the Pieris website for 90 days following the event.
About Pieris Pharmaceuticals:
Pieris is a clinical-stage biotechnology company that combines leading protein engineering capabilities and deep understanding into molecular drivers of disease to develop inhaled medicines that drive local biology to produce superior clinical outcomes for patients. Our pipeline is focused on inhalable Anticalin proteins to treat respiratory diseases and locally-activated bispecifics for immuno-oncology. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by strong partnerships with leading pharmaceutical companies. For more information, visit www.pieris.com.
Investor Relations Contact:
Pieris Pharmaceuticals, Inc.
[email protected]
Joe Patneaude
Kendall Investor Relations
[email protected]
SOURCE: Pieris Pharmaceuticals, Inc.
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationNEW YORK CITY, New York: Elon Musk is taking a big step toward making his long-promised robotaxi dream a reality. Over the weekend,...
PLANO, Texas: Toyota Motor will raise prices across a range of vehicles in the United States starting next month, the Japanese automaker...
WASHINGTON, D.C.: U.S. business activity showed signs of softening in June while inflationary pressures continued to build, driven...
NEW YORK, New York - U.S. stock markest closed sharply higher on Tuesday as a truce entered into between Irsael and Iran after 12 days...
MENLO PARK, California: Meta is taking another swing at smart eyewear—this time with a sporty edge. The company announced a new partnership...
NEW YORK CITY, New York: U.S. stocks went up and oil prices fell this week as investors hoped that Iran would not block the global...
MADISON, Wisconsin: Tens of millions of residents across the Midwest and East Coast faced dangerously high temperatures over the weekend...
ABU DHABI, 19th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi has become the first and only research hospital in the UAE to receive...
ABU DHABI, 17th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully introduced continuous infusion...
ABU DHABI, 9th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi has successfully performed the UAE's first robotic cytoreductive surgery...
ABU DHABI,16th May, 2025 (WAM) - Oracle Health, Cleveland Clinic, and G42 today announced a strategic partnership to develop a groundbreaking...
ABU DHABI, 6th May, 2025 (WAM) -- PureHealth and its subsidiary SEHA have partnered with the number one US children's hospital, Cincinnati...